Investigation of the Effects of Interlaminar Epidural Steroid Injection on Upper Extremity Proprioception in Patients With Chronic Cervical Radiculopathy
NCT ID: NCT07307846
Last Updated: 2025-12-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
46 participants
INTERVENTIONAL
2025-12-25
2026-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This prospective interventional study aims to evaluate changes in upper extremity proprioception following unilateral ILESI in patients with cervical disc herniation-related chronic radiculopathy. A secondary aim is to investigate the relationship between proprioceptive changes and clinical outcomes such as pain, neuropathic pain, disability, grip strength, and quality of life.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Interlaminar epidural steroid injection (ILESI) is a commonly used minimally invasive treatment for cervical disc herniation-associated radicular pain and has been shown to reduce pain and improve function and disability. However, its potential effects on upper extremity proprioception, an important sensory component contributing to coordinated movement and rehabilitation outcomes, remain unknown.
This prospective interventional study will evaluate proprioceptive changes using the PRO-Reach upper extremity joint position sense test, a validated multi-planar assessment method that measures joint position error across multiple directions without requiring computerized or robotic devices. Clinical outcome measures will include neuropathic pain scores, pain intensity, disability indices, hand-grip strength, and health-related quality of life. All assessments will be performed at three time points: before treatment (T0), 3 weeks after injection (T1), and 3 months after injection (T2).
Participants will undergo standardized unilateral ILESI at the C7-T1 interlaminar level under fluoroscopic guidance using a combination of corticosteroid, local anesthetic, and saline. Data collection will be performed by blinded assessors to minimize measurement bias.
The study aims to characterize whether ILESI provides measurable improvements in upper extremity proprioception and to determine the extent to which changes in proprioceptive accuracy correspond to changes in pain, neuropathic symptoms, upper extremity function, and quality of life. These findings may help guide rehabilitation planning and provide insight into the sensorimotor consequences of cervical radiculopathy and its interventional treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cervical Radiculopathy- Interlaminar Epidural Steroid Injection (ILESI) Group
Participants diagnosed with chronic unilateral cervical radiculopathy due to cervical disc herniation will undergo a standardized interlaminar epidural steroid injection. All evaluations (proprioception, pain, neuropathic pain, disability, grip strength, and quality of life) will be performed at baseline (T0), 3 weeks post-procedure (T1), and 3 months post-procedure (T2).
Interlaminar Epidural Steroid Injection (ILESI)
The injection will be administered under sterile conditions with fluoroscopic guidance at the C7-T1 interlaminar level. An 18-gauge epidural needle will be advanced into the epidural space, followed by injection of a mixture containing: 80 mg triamcinolone acetonide, 1 mL of 2% lidocaine, and 2 mL of 0.9% saline.
Participants will remain under observation for approximately 2 hours after the procedure and will then be discharged. The procedure will be performed by an experienced pain medicine specialist with over 15 years of fluoroscopic interventional practice.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interlaminar Epidural Steroid Injection (ILESI)
The injection will be administered under sterile conditions with fluoroscopic guidance at the C7-T1 interlaminar level. An 18-gauge epidural needle will be advanced into the epidural space, followed by injection of a mixture containing: 80 mg triamcinolone acetonide, 1 mL of 2% lidocaine, and 2 mL of 0.9% saline.
Participants will remain under observation for approximately 2 hours after the procedure and will then be discharged. The procedure will be performed by an experienced pain medicine specialist with over 15 years of fluoroscopic interventional practice.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female or male, 18-65 years of age
* Presence of unilateral cervical radicular pain lasting at least 3 months
* MRI of the cervical spine within the last 12 months demonstrating at least one cervical disc herniation consistent with the patient's symptoms
* Diagnosed with chronic cervical radiculopathy based on history, physical examination, and clinical evaluation
* Ability to read and write (literacy)
* Willingness to participate and ability to provide written informed consent
Exclusion Criteria
* Cervical physical therapy or cervical spinal injection performed within the past 6 months
* Symptoms or diagnosis of upper extremity entrapment neuropathy
* Documented vitamin B12 deficiency or vitamin D deficiency on laboratory results within the past year
* History of cervical spine surgery or significant cervical trauma
* Bilateral cervical radicular pain
* Cervical spinal stenosis
* History of upper extremity surgery or significant upper extremity trauma
* Cognitive impairment, major psychiatric disorder, intellectual disability, or history of significant neurological disease
* Diagnosis of polyneuropathy
* Diagnosis of Diabetes Mellitus
* Diagnosis of fibromyalgia
* Current use of medications that may impair proprioception or have sedative effects (e.g., gabapentinoids, antidepressants, muscle relaxants)
* Active local or systemic infection
* Coagulopathy or bleeding diathesis
* Known allergy to any components of the planned injection (triamcinolone, lidocaine, saline, contrast medium)
* Pregnancy
* Inability or unwillingness to provide informed consent
* Illiteracy (unable to read or write)
Withdrawal Criteria
* Voluntary withdrawal of consent at any time
* Inability or unwillingness to continue study participation for any reason
* New medical condition or event after enrollment that renders continuation unsafe according to the investigator's judgment
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marmara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Savaş Şencan, Assoc. Prof., Pain Medicine
Role: STUDY_DIRECTOR
Algology Division, Department of Physical Medicine and Rehabilitation, Marmara University Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marmara University Pendik Training and Research Hospital
Pendik, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Gökçenur Yalçın, M.D., PMR Specialist
Role: CONTACT
Phone: +90 216 625 45 45
Email: [email protected]
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gökçenur Yalçın, M.D., PMR Specialist
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Marmara-FTR-GNY-03
Identifier Type: -
Identifier Source: org_study_id